Urgent.News

What's breaking now, across thousands of outlets.

Business

Daimler Truck increases profit in the third quarter by 73 percent

The positive development is attributed to a recovering market situation.

Translated from German Read in German

Frankfurt - Daimler Truck reported a significant boost in profit for the third quarter, thanks to a turnaround in its key North American market. The company's adjusted operating result jumped from a loss of 648 million euros in the same period last year to 1.124 billion euros from July to September, according to the truck builder, which announced the news on Friday.

Revenue in the industrial segment rose by 20 percent to 11.6 billion euros, surpassing analysts' average estimate of 11.7 billion euros. The adjusted revenue margin improved by three percentage points to 9.1 percent. The recovery was driven primarily by strong sales growth and higher profitability in the Trucks North America division.

There, sales increased by 51 percent as freight operators renewed their fleets after three years of restraint. Overall, the company sold about 91,000 trucks and buses in the summer, a 26 percent increase compared to the previous year. "Our third-quarter results demonstrate that our business is gaining momentum," said Daimler Truck's CEO Karin Rådström.

The group reaffirmed its forecast for the full year 2026, expecting an adjusted revenue margin in the industrial segment of between seven and nine percent.

Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at derstandard.at →

More in Business

Metavia Reports DA-1726 Cuts Liver Fat

Metavia, an affiliate of Dong-A ST, announced interim analysis results from Part 3B of the Phase 1 clinical trial of DA-1726 at the Precision Liver Symposium 2026 held in Denver, the United States, on…

  • DA-1726 reduces liver fat by 68% in obese adults over 16 weeks
  • 83% of treatment group patients achieve >30% liver fat reduction
  • Glycated hemoglobin (HbA1c) improves by 0.44 percentage points

More from Friday 6 November →